| Financial Year |
March 31 2023 |
| Monetary Funds |
140,100,733,276.00 |
| Held-for-trading Financial Assets |
2,371,771,753.00 |
| Notes Receivable |
2,840,882,992.00 |
| Accounts Receivable |
108,405,255,926.00 |
| Advances to Suppliers |
38,352,550,809.00 |
| Other Receivables |
45,309,808,735.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
948,738,414.00 |
| Inventories |
86,303,913,660.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
69,820,574,706.00 |
| Other Current Assets |
22,122,245,703.00 |
| Total Current Assets |
686,099,005,248.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
203,406,733,755.00 |
| Long-term Equity Investment |
101,219,747,977.00 |
| Investment Properties |
12,478,769,971.00 |
| Fixed Assetes |
49,541,599,987.00 |
| Under-construction Projects |
11,374,058,502.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
234,403,263,131.00 |
| R&D expenses |
317,631,699.00 |
| Goodwill |
5,078,142,150.00 |
| Long-Term Deferred and Prepaid Expenses |
1,148,585,729.00 |
| Deferred Income Tax Assets |
8,241,632,204.00 |
| Other Non-Current Assets |
262,702,937,954.00 |
| Sub-Total of Non-Current Assets |
947,264,507,965.00 |
| Total Assets |
1,633,363,513,213.00 |
| Short-Term Loans |
77,992,852,603.00 |
| Trading Financial liabilities |
5,966,836.00 |
| Notes Payable |
46,885,074,919.00 |
| Accounts Payable |
314,355,789,483.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,408,493,003.00 |
| Taxes Payable |
13,378,292,267.00 |
| Interest Payable |
-- |
| Dividend Payable |
1,981,990,394.00 |
| Other payables |
76,955,980,317.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
63,052,156,146.00 |
| Other Current Liabilities |
57,266,114,388.00 |
| Sub-Total of Current Liabilities |
735,626,966,176.00 |
| Long-term Loans |
379,587,822,228.00 |
| Bonds Payable |
26,308,594,063.00 |
| Long-Term Accounts Payable |
44,752,441,618.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,014,940,081.00 |
| Deferred Income Tax Liabilities |
5,157,329,512.00 |
| Other Non-Current Liabilities |
758,040,934.00 |
| Sub-Total of Non-Current Liabilities |
463,533,215,294.00 |
| Total Liabilities |
1,199,160,181,470.00 |
| Paid-In Capital(Or Share Stock) |
16,165,711,425.00 |
| Capital Surplus |
38,051,640,988.00 |
| Surplus Reserve |
9,023,418,248.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
169,459,382,669.00 |
| Minority Stockholder's Interest |
146,539,791,707.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
287,663,540,035.00 |
| Owner's Equity（Stockholder's Equity） |
434,203,331,742.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,633,363,513,213.00 |
